Pharma Mar SA(DE:PMRA)
€69.200.00 (0.00%)
DE:PMRA
Pharma Mar SA earnings date
€69.20
At close:0.00 (0.00%)
Pharma Mar SA (PMRA) Q2 2026 Earnings Report
0 Followers
DE:PMRA Q2 2026 EPS Results
- Actual EPS
- -EUR 0.06
- Consensus EPS
- EUR 0.18
- Beat/Miss
- Missed by -EUR 0.24
- One Year Ago EPS
- EUR 1.33
DE:PMRA Q2 2026 Revenue Results
- Actual Revenue
- EUR 49.60M
- Expected Revenue
- EUR 44.98M
- Beat/Miss
- Beat by +EUR 4.63M
- YoY Revenue Growth
- -12.04%
Earnings Announcement Details
- Quarter
- Q2 2026
- Date
- 07/29/2026
- Time
- TBA
- Conference Call
- Wednesday, July 29, 2026
DE:PMRA Upcoming Earnings
Pharma Mar SA's next earnings date is estimated for March 1, 2027, based on past reporting schedules.
Q2 2026 Earnings Call Audio
DE:PMRA Q2 2026 Earnings Call
0:00 / 0:00
Q2 2026 Earnings Slide Deck
No slide deck is available for this earnings event.
Q2 2026 Earnings Call Summary
No earnings call summary is available for this earnings event.
DE:PMRA Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Mar 01, 2027 | 2026 (Q4) | 0.98- | 3.33 | ― | ― |
| Oct 29, 2026 | 2026 (Q3) | 0.130.47 | -0.13 | 461.54% (+0.60) | |
| Jul 29, 2026 | 2026 (Q2) | 0.18-0.06 | 1.32 | -104.53% (-1.39) | |
| Apr 23, 2026 | 2026 (Q1) | 0.130.09 | -0.11 | 181.82% (+0.20) | |
| Feb 27, 2026 | 2025 (Q4) | 3.073.33 | 1.04 | 219.14% (+2.29) | |
| Oct 30, 2025 | 2025 (Q3) | -0.15-0.13 | 0.2 | -165.00% (-0.33) | |
| Jul 30, 2025 | 2025 (Q2) | ―1.32 | 0.07 | 1938.46% (+1.26) | |
| Apr 24, 2025 | 2025 (Q1) | 0.32-0.11 | 0.12 | -191.67% (-0.23) | |
| Feb 28, 2025 | 2024 (Q4) | 0.971.04 | -0.38 | 375.00% (+1.43) | |
| Oct 29, 2024 | 2024 (Q3) | 0.200.20 | 0.08 | 150.00% (+0.12) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed
